Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Federal Drug Price Negotiation Plan To Be Proposed By Maine Rep. Michaud

Executive Summary

A federal drug price negotiation plan based on the Maine Rx program will be introduced by Rep. Michael Michaud (D-Maine), the first-term Congressman told a Jan. 21 press briefing in Washington, D.C

You may also be interested in...



Michigan Rx List Is More Restrictive Than Private Plans, Kaiser Study Says

The Michigan Medicaid preferred drug list is more restrictive in several therapeutic categories than other pharmacy benefit plans, a Kaiser Family Foundation study says

Medicaid Waivers, State Relief Issues To Be Featured In House Hearings

The House Energy & Commerce Committee is planning a series of hearings on the best ways to relieve struggling state Medicaid programs

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS041152

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel